Cholinesterases, a target of pharmacology and toxicology
Language English Country Czech Republic Media print
Document type Journal Article, Review
PubMed
22286807
DOI
10.5507/bp.2011.036
Knihovny.cz E-resources
- MeSH
- Acetylcholinesterase physiology MeSH
- Alzheimer Disease physiopathology MeSH
- Butyrylcholinesterase physiology MeSH
- Chemical Warfare Agents pharmacology poisoning MeSH
- Cholinesterase Inhibitors chemistry pharmacology poisoning MeSH
- Cholinesterases chemistry pharmacology physiology MeSH
- Humans MeSH
- Synaptic Transmission physiology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Acetylcholinesterase MeSH
- Butyrylcholinesterase MeSH
- Chemical Warfare Agents MeSH
- Cholinesterase Inhibitors MeSH
- Cholinesterases MeSH
BACKGROUND: Cholinesterases are a group of serine hydrolases that split the neurotransmitter acetylcholine (ACh) and terminate its action. Of the two types, butyrylcholinesterase and acetylcholinesterase (AChE), AChE plays the key role in ending cholinergic neurotransmission. Cholinesterase inhibitors are substances, either natural or man-made that interfere with the break-down of ACh and prolong its action. Hence their relevance to toxicology and pharmacology. METHODS AND RESULTS: The present review summarizes current knowledge of the cholinesterases and their inhibition. Particular attention is paid to the toxicology and pharmacology of cholinesterase-related inhibitors such as nerve agents (e.g. sarin, soman, tabun, VX), pesticides (e.g. paraoxon, parathion, malathion, malaoxon, carbofuran), selected plants and fungal secondary metabolites (e.g. aflatoxins), drugs for Alzheimer's disease (e.g. huperzine, metrifonate, tacrine, donepezil) and Myasthenia gravis (e.g. pyridostigmine) treatment and other compounds (propidium, ethidium, decamethonium). CONCLUSIONS: The crucial role of the cholinesterases in neural transmission makes them a primary target of a large number of cholinesterase-inhibiting drugs and toxins. In pharmacology, this has relevance to the treatment of neurodegenerative disorders.
References provided by Crossref.org
Carltonine-derived compounds for targeted butyrylcholinesterase inhibition
Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention
Biosensors and Bioassays Based on Lipases, Principles and Applications, a Review
Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine
Anti-Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase
Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates
Postponed effect of neostigmine on oxidative homeostasis
Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity
Sulfur mustard induced oxidative stress and its alteration using asoxime (HI-6)
Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase
Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology